Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

NCT04915807 · clinicaltrials.gov ↗

UNKNOWN

Status

222

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Ramucirumab and paclitaxel
DRUG: Taxane, irinotecan, or fluoropyrimidine-based single or combined chemotherapy

Sponsor

Hallym University Medical Center